Skip to main content

Advertisement

ADVERTISEMENT

News

News
11/30/2021
November 30, 2021 — One in five individuals avoided healthcare during lockdown in the COVID-19 pandemic, often for potentially urgent symptoms, according to a new study publishing Nov. 23 in PLOS Medicine by Silvan Licher of Erasmus...
November 30, 2021 — One in five individuals avoided healthcare during lockdown in the COVID-19 pandemic, often for potentially urgent symptoms, according to a new study publishing Nov. 23 in PLOS Medicine by Silvan Licher of Erasmus...
November 30, 2021 — One in five...
11/30/2021
Cath Lab Digest
News
11/29/2021
November 29, 2021 — Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That's the finding of a study published today in ESC Heart Failure, a journal...
November 29, 2021 — Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That's the finding of a study published today in ESC Heart Failure, a journal...
November 29, 2021 — Aspirin use...
11/29/2021
Cath Lab Digest
News
11/29/2021
Penn Medicine study shows that higher initial prescriptions can lead to longer-term opioid use.
Penn Medicine study shows that higher initial prescriptions can lead to longer-term opioid use.
Penn Medicine study shows that...
11/29/2021
EP Lab Digest

Advertisement

News
11/29/2021
Acutus’ Catheter-Based Therapy Platform, AcQBlate Force, Will Integrate Multiple Ablation Modalities Guided by Novel Noncontact Mapping Technology to Treat Complex Atrial Arrhythmias
Acutus’ Catheter-Based Therapy Platform, AcQBlate Force, Will Integrate Multiple Ablation Modalities Guided by Novel Noncontact Mapping Technology to Treat Complex Atrial Arrhythmias
Acutus’ Catheter-Based Therapy...
11/29/2021
EP Lab Digest
News
11/22/2021
The anticoagulants currently used to prevent strokes in dialysis patients with atrial fibrillation do not provide adequate protection for this group.
The anticoagulants currently used to prevent strokes in dialysis patients with atrial fibrillation do not provide adequate protection for this group.
The anticoagulants currently...
11/22/2021
EP Lab Digest
News
11/22/2021
New data shows improved deep learning algorithm performs equally across all age groups, enabling more patients to benefit from the company's cardiac diagnostics AI platform.
New data shows improved deep learning algorithm performs equally across all age groups, enabling more patients to benefit from the company's cardiac diagnostics AI platform.
New data shows improved deep...
11/22/2021
EP Lab Digest

Advertisement

News
11/18/2021
Remote patient monitoring and management company recognized for continued innovation and growth.
Remote patient monitoring and management company recognized for continued innovation and growth.
Remote patient monitoring and...
11/18/2021
EP Lab Digest
News
11/18/2021
A new study finds that patients with atrial fibrillation, the most common type of heart arrhythmia in adults, are at significantly higher risk to experience serious complications from COVID-19 illness.
A new study finds that patients with atrial fibrillation, the most common type of heart arrhythmia in adults, are at significantly higher risk to experience serious complications from COVID-19 illness.
A new study finds that patients...
11/18/2021
EP Lab Digest
News
11/18/2021
Cardiologs announced the results of a clinical study that proved Cardiologs' deep learning AI outperforms the Apple Watch ECG algorithm in the detection of atrial arrhythmias, which are related to stroke risks.
Cardiologs announced the results of a clinical study that proved Cardiologs' deep learning AI outperforms the Apple Watch ECG algorithm in the detection of atrial arrhythmias, which are related to stroke risks.
Cardiologs announced the results...
11/18/2021
EP Lab Digest

Advertisement

News
11/17/2021
U.S. Food and Drug Administration approval of a clinical trial of Cardialen’s low-energy defibrillation and cardioversion therapy expands the number of leading clinical institutions evaluating its promising MultiPulse™ Therapy.
U.S. Food and Drug Administration approval of a clinical trial of Cardialen’s low-energy defibrillation and cardioversion therapy expands the number of leading clinical institutions evaluating its promising MultiPulse™ Therapy.
U.S. Food and Drug...
11/17/2021
EP Lab Digest

Advertisement